These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 840146)

  • 21. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis.
    Clark-Pearson DL; DeLong E; Synan IS; Soper JT; Creasman WT; Coleman RE
    Obstet Gynecol; 1990 Apr; 75(4):684-9. PubMed ID: 2179782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic properties of heparin in a neonatal piglet model of thrombin-induced thrombosis.
    Schmidt B; Buchanan MR; Ofosu F; Brooker L; Hirsh J; Andrew M
    Thromb Haemost; 1988 Oct; 60(2):289-92. PubMed ID: 3217922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemostatic molecular markers in patients undergoing radical retropubic prostatectomy for prostate cancer and submitted to prophylaxis with unfractioned or low molecular weight heparin.
    Boncinelli S; Marsili M; Lorenzi P; Fabbri LP; Pittino S; Filoni M; Bressan F; Sarti E; Cinotti S; Morfini M
    Minerva Anestesiol; 2001 Oct; 67(10):693-703. PubMed ID: 11740417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of action of low doses of subcutaneous heparin (author's transl)].
    Duckert F
    Ther Umsch; 1977 May; 34(5):334-7. PubMed ID: 867313
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombin inhibiting action of heparin.
    Abildgaard U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):408-16. PubMed ID: 4121334
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of low molecular weight heparin on the hemostatic system after abdominal surgery.
    Schmitz-Huebner U; Rüschemeyer C; Schulte H; van de Loo J
    Thromb Haemost; 1985 Jun; 53(3):297-300. PubMed ID: 3901387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Heparin clearance during activation of the anticoagulation system in animals].
    Ul'ianov AM
    Biull Eksp Biol Med; 1978 Jun; 85(6):651-4. PubMed ID: 667338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications of heparin therapy.
    Gervin AS
    Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Subcutaneous small heparin doses for the prevention of thrombosis in general surgery and urology].
    Rem J; Duckert F; Fridrich R; Gruber UF
    Schweiz Med Wochenschr; 1975 Jun; 105(26):827-35. PubMed ID: 1215880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J; Kirchhofer D; Riederer M; Tschopp TB; Steiner B; Roux SP
    Thromb Haemost; 1997 Sep; 78(3):1142-9. PubMed ID: 9308768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin].
    Pindur G; Köhler M; Heiden M; Leipnitz C; Rupp KH; Wenzel E
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1149-55. PubMed ID: 1983502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo assessment of anticoagulation.
    Blaisdell FW; Graziano CJ; Effeney DJ
    Surgery; 1977 Dec; 82(6):827-39. PubMed ID: 929373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinogen survival in cirrhosis: improvement by "low dose" heparin.
    Coleman M; Finlayson N; Bettigole RE; Sadula D; Cohn M; Pasmantier M
    Ann Intern Med; 1975 Jul; 83(1):79-81. PubMed ID: 1147442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of complex thrombin-heparin formation in the clearance of thrombin in the blood stream and the role of liver and lungs in the absorption of heparin-complexes (author's transl)].
    Kudrjashov BA; Liapina LA; Uljanov AM; Kovaleva TN; Strukova SM
    Thromb Res; 1976 Feb; 8(2):205-15. PubMed ID: 1251351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.